Brief: Sakar Healthcare Says Granted Second Marketing Authorization For Oncology Injection In EU
18/06/2025 09:18
June 18 (Reuters) - Sakar Healthcare Ltd SAKA.NS: GRANTED SECOND MARKETING AUTHORIZATION FOR ONCOLOGY INJECTION IN EU Source text: ID:nNSE9thWNc Further company coverage: SAKA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sakar Healthcare
See all newsBrief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
Brief: Sakar Healthcare Says Granted Two More Marketing Authorizations In EU
India's Sakar Healthcare rises on nod to market cancer injection in EU